Neurology
Predictors of recurrent stroke after embolic stroke of undetermined source.
9 Jun, 2022 | 10:32h | UTC
Systematic Review: Cannabis-based products for chronic pain.
7 Jun, 2022 | 11:47h | UTCCannabis-Based Products for Chronic Pain: A Systematic Review – Annals of Internal Medicine
Annals Video Summary: Cannabis-Based Products for Chronic Pain: A Systematic Review
Summary for Patients: Cannabis-Based Products for Chronic Pain
Related:
Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders
M-A: Birth outcomes of neonates exposed to marijuana in utero.
Cannabis-related allergies: an international overview and consensus recommendations.
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Review: Considerations for cannabinoids in perioperative care by anesthesiologists.
Review: Cannabis-based Medicines and the Perioperative Physician
Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know
Prospective evaluation of autonomic dysfunction in patients with post-acute sequela of COVID-19.
7 Jun, 2022 | 11:38h | UTCCommentary: Autonomic Dysfunction in Post-Acute Sequela of COVID-19 – American College of Cardiology
Prognostic indicators and outcomes of hospitalized COVID-19 patients with neurological disease: An individual patient data meta-analysis.
7 Jun, 2022 | 11:36h | UTC
Systematic Review: Interventions for preventing falls in Parkinson’s disease.
7 Jun, 2022 | 11:18h | UTCInterventions for preventing falls in Parkinson’s disease- Cochrane Library
Summary: Interventions for preventing falls in Parkinson’s disease – Cochrane Library
Podcast: Medical cannabis pearls.
6 Jun, 2022 | 10:58h | UTC#338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders
Guidelines on stroke in women: management of menopause, pregnancy and postpartum.
2 Jun, 2022 | 11:27h | UTC
Cohort Study: Evaluation of neurologic and psychiatric outcomes after hospital discharge among adult survivors of cardiac arrest.
2 Jun, 2022 | 10:15h | UTC
Cohort Study: Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability.
1 Jun, 2022 | 11:44h | UTCAuthor Interview: Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability – JAMA
Commentaries:
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism – HealthDay
Related:
Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs – Neurology (link to abstract – $ for full-text)
Educational attainment of children born to mothers with epilepsy – Journal of Neurology, Neurosurgery, and Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
Nordic study of 4.5 million children found an association between prenatal exposure to topiramate and valproate and child intellectual disability and #autism. https://t.co/UH2THznPiV
— JAMA Neurology (@JAMANeuro) May 31, 2022
Cohort Study: Complicated carotid artery plaques and risk of recurrent ischemic stroke or TIA.
1 Jun, 2022 | 11:19h | UTCCommentary: Complicated Carotid Plaques and Risk of Recurrent Ischemic Stroke or TIA – American College of Cardiology
Commentary on Twitter
#ESOC2022 #JACC SimPub: Complicated #CarotidArtery plaques increase risk of recurrent ischemic #stroke or transient #ischemicattack in pts w/ ischemic stroke & undetermined stroke etiology. https://t.co/io9aUdX8cT
Editorial: https://t.co/H5ReNFnEAS #StrokeMonth #CardioTwitter pic.twitter.com/aYZEPrMmeZ
— JACC Journals (@JACCJournals) May 3, 2022
Association between retinal layer thickness and cognitive decline in older adults.
1 Jun, 2022 | 11:13h | UTCCommentaries:
Retinal Layer Thickness Linked to Risk of Cognitive Decline – NeurologyToday
Retinal Layer Thickness Linked to Cognitive Decline in Older Adults – HealthDay
Commentary on Twitter
The thickness of macular retinal nerve fiber layers could be a prognostic biomarker of long-term #cognitivedecline in adults ages 60 or older, says @JAMAOphth study. #neurotwitter @AANMember #neurology https://t.co/gKzIEfzimX pic.twitter.com/6uwwS5gmEC
— Neurology Today (@NeurologyToday) May 31, 2022
Review | Long-term cardiac monitoring after embolic stroke of undetermined source. Search longer – look harder.
1 Jun, 2022 | 10:52h | UTC
Delirium: How can we protect our patients? Detection and treatment strategies.
31 May, 2022 | 11:10h | UTCRelated:
Less pharmacotherapy is more in delirium – Intensive Care Medicine
Effectiveness of Bundle Interventions on ICU Delirium: A Meta-Analysis – Critical Care Medicine
Evidence-based recommendations on texture modified foods and thickened liquids for adults with oropharyngeal dysphagia – “There is no convincing evidence that thickened liquid or texture modified diet prevents death or pneumonia nor improves the quality of life, nutritional status, or oral intake in individuals with OD”.
30 May, 2022 | 11:54h | UTC
Combined bacterial meningitis and infective endocarditis: when should we search for the other when either one is diagnosed?
30 May, 2022 | 11:22h | UTC
Cohort Study: Seven healthy habits linked to lower risk of dementia in those with genetic risk.
30 May, 2022 | 10:54h | UTCNews Release: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology
Original Study: Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text)
Commentary: Healthy Lifestyle May Lower Dementia Risk Despite Genetics – HealthDay
Commentary on Twitter
Seven healthy habits-Life’s Simple 7: being active, eating better, losing weight, not smoking, maintaining a healthy blood pressure, controlling cholesterol, and reducing blood sugar are associated with a lower risk of dementiahttps://t.co/NAGB2AkKc0
— K Pavithran (@drkpavithran) May 26, 2022
Living clinical guidelines for stroke: updates, challenges, and opportunities.
27 May, 2022 | 12:01h | UTCOriginal Guideline: The Australian and New Zealand Clinical Guidelines for Stroke Management
M-A: Surgical timing in patients with infective endocarditis and with intracranial hemorrhage.
27 May, 2022 | 11:25h | UTC
Commentary from the author on Twitter
Check out the results of our meta-analysis regarding operation timing in endocarditis patients with intracranial hemorrhage.
An interesting highlight is the evident immortal-time bias present in most studies. See more: https://t.co/6YskZPIXWB@HrisKirov @MahmDiab @ToDoenst pic.twitter.com/HvcbjTQAjT
— Tulio Caldonazo, MD (@TulioCaldonazo) May 17, 2022
Under a Creative Commons Attribution‐Noncommercial License
Systematic Review: Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
26 May, 2022 | 10:25h | UTCSummary: Treatment of unintentional drooling of saliva in motor neuron disease – Cochrane Library
Retrospective Cohort Study: The incidence of ischemic stroke in patients with asymptomatic severe carotid stenosis (70% to 99%) without surgical intervention was 4.7% over 5 years.
25 May, 2022 | 11:48h | UTCIncidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention – JAMA (free for a limited period)
News Release: Low stroke risk in patients with very narrowed neck arteries – Kaiser Permanente
Study Commentary: Cerebrospinal fluid biomarkers for depression.
25 May, 2022 | 10:59h | UTCCerebrospinal fluid biomarkers for depression – The Mental Elf
Original Study: Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals: A Systematic Review and Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
Comprehensive systematic review and meta-analysis of all cerebrospinal fluid studies in #depression investigating contrast to healthy controls (165 biomarkers from 97 studies) pointing at several biological mechanisms and future directions. https://t.co/gcjFBjYJhi @MichaelBenros
— JAMA Psychiatry (@JAMAPsych) April 25, 2022
Systematic Review: Ocrelizumab for multiple sclerosis.
25 May, 2022 | 10:47h | UTCOcrelizumab for multiple sclerosis – Cochrane Library
Summary: What are the benefits and risks of ocrelizumab for multiple sclerosis? – Cochrane Library
Review | Perioperative brain health in the older adult: a patient safety imperative.
24 May, 2022 | 08:03h | UTCPerioperative Brain Health in the Older Adult: A Patient Safety Imperative – Anesthesia & Analgesia (free for a limited period)
Guidelines for management of medical emergencies associated with psychotropic medications.
24 May, 2022 | 08:06h | UTC
Drugs for agitation in people with dementia: benefits and risks.
23 May, 2022 | 01:25h | UTCDrugs for agitation in people with dementia: benefits and risks – Evidently Cochrane
Original Study: Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library
Commentary on Twitter (thread – click for more)
New blog for #DementiaActionWeek: https://t.co/UT1sdwNZRv @CharSquires & @jamie_garr look at the @CochraneDCIG evidence on drugs used to treat agitation & psychosis in people with #dementia & reflect on what doctors & families may want to consider when making treatment decisions pic.twitter.com/Ei7njr3ynL
— Cochrane UK (@CochraneUK) May 20, 2022